Sort
53,477 grants matching “addiction”
The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy
$763,288Krista F Huybrechts · Brigham And Women'S Hospital · R01 · FY2025 · DA
Novel SCD1 inhibitors for treatment of cancer
$763,181John A Copland · Modulation Therapeutics, Inc. · R42 · FY2018 · CA
Training and Education Core p270-287
$762,939Thomas Evan Eissenberg · Virginia Commonwealth University · P50 · FY2017 · DA
Administrative Core
$762,928Rick A Bevins · University Of Nebraska Lincoln · P20 · FY2023 · GM
Statewide System and Organizational Strategy for Evidence-Based Practice Implementation and Sustainment in Substance Use Disorder Treatment
$762,880Gregory Aarons · University Of California, San Diego · R01 · FY2020 · DA
Implementing statewide emergency department care pathways for addiction recovery after opioid overdose
$762,747Francesca Beaudoin · Rhode Island Hospital · R01 · FY2021 · CE
Phase II of BUILDing SCHOLARS - Student Training Core
$762,510Thomas Boland · University Of Texas El Paso · TL4 · FY2020 · GM
Molecular Codes for the Establishment of Functionally Segregated Dopaminergic Circuits
$762,394Hisashi Umemori · Boston Children'S Hospital · R01 · FY2023 · MH
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
$762,311Lori E Fantry · University Of Arizona · R01 · FY2024 · DA
The VesiVax® System: Vaccine Development Made Easy
$762,253Samon Ho · Molecular Express, Inc. · R44 · FY2016 · AI
Integrating Addiction Research in Health Systems: The Addiction Research Network
$762,184Cynthia I Campbell · Kaiser Foundation Research Institute · UG1 · FY2015 · DA
Project 1: Enhancing the Economic Impact Analysis used in FDA's Rules p150-201
$762,069Michael Paul Eriksen · Georgia State University · P50 · FY2016 · DA
Cocaine Addition and the Need-State Hypothesis
$762,063Patricia Sue Grigson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · DA
Validation of electrophysiological biomarkers associated with performance in a preclinical assay of sustained attention
$762,036Gregory V Carr · Lieber Institute, Inc. · R01 · FY2025 · MH
Neurofunctional phenotyping to investigate the role of the orexin system at the intersection of opioid use disorder and insomnia
$762,021Caitlin Eileen Martin · Virginia Commonwealth University · R01 · FY2025 · DA
Train and EMPOWER A Community Health workforce to achieve equity and reduce disparities in mental health (TEACH)
$761,926Katherine Sanchez · University Of Texas Arlington · U01 · FY2024 · MD
Harnessing Knowledge of Gene Function in Brain Tissue for Discovering Biology Underlying Heroin Addiction
$761,916Eric O Johnson · Research Triangle Institute · R01 · FY2020 · DA
BioLuminescent OptoGenetics (BL-OG): A Novel and Versatile Strategy for Neuromodulation
$761,800Ute H Hochgeschwender · Central Michigan University · U01 · FY2016 · NS
Neurofunctional phenotyping to investigate the role of the orexin system at the intersection of opioid use disorder and insomnia
$761,711Caitlin Eileen Martin · Virginia Commonwealth University · R01 · FY2024 · DA
Professional Development Core
$761,663Ira B Wilson · Brown University · U54 · FY2020 · GM
Professional Development Core
$761,663Ira B Wilson · Brown University · U54 · FY2019 · GM
Effect of buprenorphine on monocytes in the context of neuroAids and opioid abuse
$761,502Joan Weinberger Berman · Albert Einstein College Of Medicine · R01 · FY2023 · DA
Role of FH loss in development of HLRCC heriditary kidney cancer
$761,487Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT
$761,477Yong Huang · University Of California, San Francisco · N01 · FY2012 · DA
A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)
$761,450Andrew B Norman · University Of Cincinnati · DP1 · FY2014 · DA